Original
Tratamiento de la enfermedad de injerto contra huésped crónica esclerodermiforme con imatinib: una perspectiva dermatológica
Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective
P. Molés-Povedaa,b,
, P. Montesinosa, J. Sanz-Caballera,c, B. de Unamunoa,b,d, J.L. Piñanaa,c, A. Sahuquilloa,b,e, R. Botella-Estradaa,e
a Unidad de Dermatología, Hospital Universitario y Politécnico La Fe, Valencia, España
b Instituto de Investigación Sanitaria La Fe, Valencia, España
c Grupo de Investigación en Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Valencia, España
d Grupo de Investigación Clínica y Traslacional del Cáncer, Hospital Universitario y Politécnico La Fe, Valencia, España
e Grupo de Investigación de Dermatología y Regeneración Tisular, Hospital Universitario y Politécnico La Fe, Valencia, España
Leído
13175
Vecesse ha leído el artículo
2545
Total PDF
10630
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 37 | 4 | 41 |
| 2025 5 | 156 | 33 | 189 |
| 2025 4 | 174 | 28 | 202 |
| 2025 3 | 142 | 18 | 160 |
| 2025 2 | 156 | 33 | 189 |
| 2025 1 | 102 | 33 | 135 |
| 2024 12 | 104 | 20 | 124 |
| 2024 11 | 138 | 56 | 194 |
| 2024 10 | 95 | 36 | 131 |
| 2024 9 | 94 | 18 | 112 |
| 2024 8 | 114 | 42 | 156 |
| 2024 7 | 126 | 40 | 166 |
| 2024 6 | 133 | 35 | 168 |
| 2024 5 | 107 | 31 | 138 |
| 2024 4 | 100 | 39 | 139 |
| 2024 3 | 134 | 34 | 168 |
| 2024 2 | 113 | 28 | 141 |
| 2024 1 | 115 | 20 | 135 |
| 2023 12 | 117 | 13 | 130 |
| 2023 11 | 124 | 31 | 155 |
| 2023 10 | 122 | 25 | 147 |
| 2023 9 | 131 | 23 | 154 |
| 2023 8 | 146 | 15 | 161 |
| 2023 7 | 155 | 34 | 189 |
| 2023 6 | 140 | 22 | 162 |
| 2023 5 | 200 | 26 | 226 |
| 2023 4 | 156 | 23 | 179 |
| 2023 3 | 176 | 28 | 204 |
| 2023 2 | 144 | 31 | 175 |
| 2022 1 | 115 | 34 | 149 |
| 2022 12 | 149 | 50 | 199 |
| 2022 11 | 191 | 43 | 234 |
| 2022 10 | 177 | 54 | 231 |
| 2022 9 | 156 | 51 | 207 |
| 2022 8 | 198 | 67 | 265 |
| 2022 7 | 202 | 55 | 257 |
| 2022 6 | 206 | 38 | 244 |
| 2022 5 | 262 | 39 | 301 |
| 2022 4 | 266 | 68 | 334 |
| 2022 3 | 291 | 61 | 352 |
| 2022 2 | 262 | 39 | 301 |
| 2021 1 | 268 | 55 | 323 |
| 2021 12 | 189 | 57 | 246 |
| 2021 11 | 220 | 47 | 267 |
| 2021 10 | 251 | 59 | 310 |
| 2021 9 | 174 | 56 | 230 |
| 2021 8 | 169 | 37 | 206 |
| 2021 7 | 185 | 32 | 217 |
| 2021 6 | 206 | 44 | 250 |
| 2021 5 | 183 | 38 | 221 |
| 2021 4 | 432 | 270 | 702 |
| 2021 3 | 282 | 41 | 323 |
| 2021 2 | 167 | 41 | 208 |
| 2020 1 | 159 | 25 | 184 |
| 2020 12 | 141 | 28 | 169 |
| 2020 11 | 139 | 36 | 175 |
| 2020 10 | 116 | 19 | 135 |
| 2020 9 | 142 | 28 | 170 |
| 2020 8 | 129 | 23 | 152 |
| 2020 7 | 152 | 21 | 173 |
| 2020 6 | 124 | 35 | 159 |
| 2020 5 | 267 | 30 | 297 |
| 2020 4 | 115 | 25 | 140 |
| 2020 3 | 86 | 20 | 106 |
| 2020 2 | 6 | 0 | 6 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 5 | 2 | 7 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 5 | 2 | 7 |
| 2019 8 | 5 | 0 | 5 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 8 | 0 | 8 |
| 2019 5 | 4 | 0 | 4 |
| 2019 4 | 3 | 2 | 5 |
| 2019 3 | 2 | 4 | 6 |
| 2019 2 | 15 | 2 | 17 |
| 2019 1 | 2 | 4 | 6 |
| 2018 12 | 4 | 4 | 8 |
| 2018 11 | 4 | 2 | 6 |
| 2018 10 | 3 | 2 | 5 |
| 2018 9 | 4 | 3 | 7 |
| 2018 8 | 0 | 2 | 2 |
| 2018 7 | 2 | 1 | 3 |
| 2018 6 | 6 | 2 | 8 |
| 2018 5 | 4 | 4 | 8 |
| 2018 4 | 14 | 14 | 28 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 0 | 2 | 2 |
| 2018 1 | 0 | 3 | 3 |
| 2017 12 | 0 | 3 | 3 |
Mostrar todo
